

<!DOCTYPE html>
<html lang="zh-CN" >



<head>
  <meta charset="UTF-8">

  <link rel="apple-touch-icon" sizes="76x76" href="/img/Logo.png">
  <link rel="icon" href="/img/Logo.png">
  

  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0, shrink-to-fit=no">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  
  <meta name="theme-color" content="#2f4154">
  <meta name="author" content="向海">
  <meta name="keywords" content="">
  
    <meta name="description" content="Antihypertensive drugs including Vasodilators and anti-diuretics">
<meta property="og:type" content="article">
<meta property="og:title" content="L7 Antihypertensive drugs including Vasodilators and anti-diuretics">
<meta property="og:url" content="https://zhenyumi.github.io/posts/a09a12e3/index.html">
<meta property="og:site_name" content="鹘横海">
<meta property="og:description" content="Antihypertensive drugs including Vasodilators and anti-diuretics">
<meta property="og:locale" content="zh_CN">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329201740434.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329204729716.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329204752813.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329204857399.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329205045367.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329205108089.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329234910360.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329234919058.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329235904526.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330000834292.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330002558573.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330003226229.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330003555511.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330003708111.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004101016.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004615345.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004636968.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004655595.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004824578.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004839694.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005010939.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005328041.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005339494.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005351503.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005555318.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005652765.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005928677.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005947362.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010211714.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010217026.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010550604.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010849422.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330011037971.png">
<meta property="article:published_time" content="2021-04-16T06:03:08.000Z">
<meta property="article:modified_time" content="2021-04-16T06:03:08.000Z">
<meta property="article:author" content="向海">
<meta property="article:tag" content="Molecular Pharmacology">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329201740434.png">
  
  
  
  <title>L7 Antihypertensive drugs including Vasodilators and anti-diuretics - 鹘横海</title>

  <link  rel="stylesheet" href="https://lib.baomitu.com/twitter-bootstrap/4.6.1/css/bootstrap.min.css" />



  <link  rel="stylesheet" href="https://lib.baomitu.com/github-markdown-css/4.0.0/github-markdown.min.css" />

  <link  rel="stylesheet" href="https://lib.baomitu.com/hint.css/2.7.0/hint.min.css" />

  <link  rel="stylesheet" href="https://lib.baomitu.com/fancybox/3.5.7/jquery.fancybox.min.css" />



<!-- 主题依赖的图标库，不要自行修改 -->
<!-- Do not modify the link that theme dependent icons -->

<link rel="stylesheet" href="//at.alicdn.com/t/c/font_1749284_5i9bdhy70f8.css">



<link rel="stylesheet" href="//at.alicdn.com/t/c/font_1736178_k526ubmyhba.css">


<link  rel="stylesheet" href="/css/main.css" />


  <link id="highlight-css" rel="stylesheet" href="/css/highlight.css" />
  




  <script id="fluid-configs">
    var Fluid = window.Fluid || {};
    Fluid.ctx = Object.assign({}, Fluid.ctx)
    var CONFIG = {"hostname":"zhenyumi.github.io","root":"/","version":"1.9.8","typing":{"enable":true,"typeSpeed":70,"cursorChar":"_","loop":false,"scope":["home"]},"anchorjs":{"enable":true,"element":"h1,h2,h3,h4,h5,h6","placement":"left","visible":"hover","icon":""},"progressbar":{"enable":true,"height_px":3,"color":"#29d","options":{"showSpinner":false,"trickleSpeed":100}},"code_language":{"enable":true,"default":"TEXT"},"copy_btn":true,"image_caption":{"enable":true},"image_zoom":{"enable":true,"img_url_replace":["",""]},"toc":{"enable":true,"placement":"right","headingSelector":"h1,h2,h3,h4,h5,h6","collapseDepth":0},"lazyload":{"enable":true,"loading_img":"/img/loading.gif","onlypost":false,"offset_factor":2},"web_analytics":{"enable":false,"follow_dnt":true,"baidu":null,"google":{"measurement_id":null},"tencent":{"sid":null,"cid":null},"leancloud":{"app_id":null,"app_key":null,"server_url":null,"path":"window.location.pathname","ignore_local":false},"umami":{"src":null,"website_id":null,"domains":null,"start_time":"2024-01-01T00:00:00.000Z","token":null,"api_server":null}},"search_path":"/local-search.xml","include_content_in_search":true};

    if (CONFIG.web_analytics.follow_dnt) {
      var dntVal = navigator.doNotTrack || window.doNotTrack || navigator.msDoNotTrack;
      Fluid.ctx.dnt = dntVal && (dntVal.startsWith('1') || dntVal.startsWith('yes') || dntVal.startsWith('on'));
    }
  </script>
  <script  src="/js/utils.js" ></script>
  <script  src="/js/color-schema.js" ></script>
  


  
<meta name="generator" content="Hexo 7.0.0"></head>


<body>
  

  <header>
    

<div class="header-inner" style="height: 70vh;">
  <nav id="navbar" class="navbar fixed-top  navbar-expand-lg navbar-dark scrolling-navbar">
  <div class="container">
    <a class="navbar-brand" href="/">
      <strong>鹘横海</strong>
    </a>

    <button id="navbar-toggler-btn" class="navbar-toggler" type="button" data-toggle="collapse"
            data-target="#navbarSupportedContent"
            aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
      <div class="animated-icon"><span></span><span></span><span></span></div>
    </button>

    <!-- Collapsible content -->
    <div class="collapse navbar-collapse" id="navbarSupportedContent">
      <ul class="navbar-nav ml-auto text-center">
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/" target="_self">
                <i class="iconfont icon-home-fill"></i>
                <span>首页</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/archives/" target="_self">
                <i class="iconfont icon-archive-fill"></i>
                <span>归档</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/categories/" target="_self">
                <i class="iconfont icon-category-fill"></i>
                <span>分类</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/tags/" target="_self">
                <i class="iconfont icon-tags-fill"></i>
                <span>标签</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/about/" target="_self">
                <i class="iconfont icon-user-fill"></i>
                <span>关于</span>
              </a>
            </li>
          
        
        
          <li class="nav-item" id="search-btn">
            <a class="nav-link" target="_self" href="javascript:;" data-toggle="modal" data-target="#modalSearch" aria-label="Search">
              <i class="iconfont icon-search"></i>
            </a>
          </li>
          
        
        
      </ul>
    </div>
  </div>
</nav>

  

<div id="banner" class="banner" parallax=true
     style="background: url('https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/Fluid/post/post2.jpg') no-repeat center center; background-size: cover;">
  <div class="full-bg-img">
    <div class="mask flex-center" style="background-color: rgba(0, 0, 0, 0.3)">
      <div class="banner-text text-center fade-in-up">
        <div class="h2">
          
            <span id="subtitle">L7 Antihypertensive drugs including Vasodilators and anti-diuretics</span>
          
        </div>

        
          
  <div class="mt-3">
    
    
      <span class="post-meta">
        <i class="iconfont icon-date-fill" aria-hidden="true"></i>
        <time datetime="2021-04-16 14:03" pubdate>
          2021年4月16日 下午
        </time>
      </span>
    
  </div>

  <div class="mt-1">
    
      <span class="post-meta mr-2">
        <i class="iconfont icon-chart"></i>
        
          430 字
        
      </span>
    

    
      <span class="post-meta mr-2">
        <i class="iconfont icon-clock-fill"></i>
        
        
        
          4 分钟
        
      </span>
    

    
    
  </div>


        
      </div>

      
    </div>
  </div>
</div>

</div>

  </header>

  <main>
    
      

<div class="container-fluid nopadding-x">
  <div class="row nomargin-x">
    <div class="side-col d-none d-lg-block col-lg-2">
      

    </div>

    <div class="col-lg-8 nopadding-x-md">
      <div class="container nopadding-x-md" id="board-ctn">
        <div id="board">
          <article class="post-content mx-auto">
            <h1 id="seo-header">L7 Antihypertensive drugs including Vasodilators and anti-diuretics</h1>
            
            
              <div class="markdown-body">
                
                <h1 id="一、The-definition-of-Hypertension"><a href="#一、The-definition-of-Hypertension" class="headerlink" title="一、The definition of Hypertension"></a>一、The definition of Hypertension</h1><p><strong>Hypertension:</strong> an elevation of arterial blood pressure above an arbitrarily defined normal value</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329201740434.png" srcset="/img/loading.gif" lazyload alt="image-20210329201740434" style="zoom:100%;" />

<ul>
<li>Risks of damage to <u>kidney</u>, heart and <u>brain</u> are directly related to the extent of blood pressure elevation</li>
</ul>
<h2 id="General-info-of-hypertension-HTN"><a href="#General-info-of-hypertension-HTN" class="headerlink" title="General info of hypertension (HTN)"></a>General info of hypertension (HTN)</h2><p>Nearly 90% people will develop HTN</p>
<ul>
<li>Causes are not clear for primary HTN</li>
<li>Diagnosed by Bp measurement, rather than symptoms at the early stage</li>
<li>Many complications: <ul>
<li>renal failure 肾功能衰竭</li>
<li>heart failure </li>
<li>coronary disease 冠状动脉疾病</li>
<li>Stroke (blood vessel rupture in the brain)</li>
</ul>
</li>
<li>CV diseases are pressure related<ul>
<li>From 115&#x2F;75 mmHg, each 20&#x2F;10 mmHg doubles risk</li>
</ul>
</li>
</ul>
<h2 id="The-cause-of-Hypertension"><a href="#The-cause-of-Hypertension" class="headerlink" title="The cause of Hypertension"></a>The cause of Hypertension</h2><p><strong>Essential or primary hypertension</strong>: patients with no specifc cause of hypertension can be found, account for 85-90% of patients</p>
<p><strong>Secondary hypertension:</strong> with known cause,could be due to many reasons such as <strong>renal artery constriction（肾动脉收缩）</strong>, <strong>coarctation of the aorta（主动脉缩窄）</strong>, etc.</p>
<p><strong>BP &#x3D; CO x PVR</strong>, <font color="FF0000">Cardiac Output (CO)</font> is mostly normal, whereas <font color="FF0000">peripheral vascular resistance (PVR</font>), the resistance to flow of blood through arterioles, is usually increased in hypertension</p>
<h2 id="Normal-regulation-of-BP"><a href="#Normal-regulation-of-BP" class="headerlink" title="Normal regulation of BP"></a>Normal regulation of BP</h2><p>BP &#x3D; CO x PVR</p>
<p><font color="FF0000">CO : myocardial contractility &amp; basic filling pressure</font></p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329204729716.png" srcset="/img/loading.gif" lazyload alt="image-20210329204729716" style="zoom:100%;" />

<ul>
<li>Hypertensive patients: the baroreceptors and the renal blood volume-pressure control system are set at a higher level of blood pressure</li>
</ul>
<h3 id="1-Baroreceptor-reflex"><a href="#1-Baroreceptor-reflex" class="headerlink" title="1. Baroreceptor reflex"></a>1. Baroreceptor reflex</h3><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329204752813.png" srcset="/img/loading.gif" lazyload alt="image-20210329204752813" style="zoom:100%;" />

<hr>
<p>CNS sympathetic nerves</p>
<ul>
<li>Resistance vessels</li>
<li>Capacitance vessels</li>
<li>Cardiac output</li>
<li>Basic filling pressure via kidney<ul>
<li>Renin angiotensin aldosterone system</li>
</ul>
</li>
<li>Baroreceptor reflex arc</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329204857399.png" srcset="/img/loading.gif" lazyload alt="image-20210329204857399" style="zoom: 150%;" />

<p>Local released vasoactive substances</p>
<p>Vasodilator </p>
<ul>
<li>NE</li>
<li>Nitric Oxide</li>
<li>Endothelial - NOS</li>
</ul>
<p>vasoconstrictive factors</p>
<ul>
<li>Angiotensin</li>
<li>Prostaglandins</li>
</ul>
<h3 id="2-Differences"><a href="#2-Differences" class="headerlink" title="2. Differences"></a>2. Differences</h3><h4 id="Gender-and-Ethic-difference"><a href="#Gender-and-Ethic-difference" class="headerlink" title="Gender and Ethic difference"></a>Gender and Ethic difference</h4><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329205045367.png" srcset="/img/loading.gif" lazyload alt="image-20210329205045367" style="zoom:100%;" />

<ul>
<li>The frequency distribution of the systolic pressure of 16429 undergraduates</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329205108089.png" srcset="/img/loading.gif" lazyload alt="image-20210329205108089" style="zoom:100%;" />

<h4 id="Food-Particularly-the-salt-intake"><a href="#Food-Particularly-the-salt-intake" class="headerlink" title="Food: Particularly the salt intake"></a>Food: Particularly the salt intake</h4><h4 id="Physical-exercise"><a href="#Physical-exercise" class="headerlink" title="Physical exercise"></a>Physical exercise</h4><h4 id="Conscious-control-Yuga"><a href="#Conscious-control-Yuga" class="headerlink" title="Conscious control: Yuga"></a>Conscious control: Yuga</h4><h2 id="二、Antihypertensive-drugs"><a href="#二、Antihypertensive-drugs" class="headerlink" title="二、Antihypertensive drugs"></a>二、Antihypertensive drugs</h2><h2 id="Major-sites-of-antihypertensive-drugs"><a href="#Major-sites-of-antihypertensive-drugs" class="headerlink" title="Major sites of antihypertensive drugs"></a>Major sites of antihypertensive drugs</h2><p>brain-heart-vessels-kidney</p>
<ul>
<li>Diuretics: Drugs that alter sodium and water balance (kidney)</li>
<li>Alter <strong>sympathetic NS</strong>:<ul>
<li>Centrally acting sympathoplegic drugs</li>
<li><em>Ganglion‐blocking agents</em></li>
<li>Adrenergic neuron‐blocking agents</li>
<li>Adrenoceptor antagonists: beta &amp; alpha blockers</li>
</ul>
</li>
<li>Vasodilators (<strong>Blood vessel</strong>)</li>
<li>Act on angiotensin system <strong>(kidney):</strong><ul>
<li>ACEI &amp; receptor blockers</li>
</ul>
</li>
<li>Calcium channel blockers<ul>
<li>calcium will cause constriction</li>
</ul>
</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329234910360.png" srcset="/img/loading.gif" lazyload alt="image-20210329234910360" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329234919058.png" srcset="/img/loading.gif" lazyload alt="image-20210329234919058" style="zoom:100%;" />

<h2 id="Drugs-alter-sympathetic-NS"><a href="#Drugs-alter-sympathetic-NS" class="headerlink" title="Drugs alter sympathetic NS"></a>Drugs alter sympathetic NS</h2><h3 id="1-Drugs"><a href="#1-Drugs" class="headerlink" title="1. Drugs"></a>1. Drugs</h3><ul>
<li>methyldopa 甲基多巴</li>
<li>Clonidine 可乐定</li>
<li>Guanethidine 胍乙啶</li>
<li>Reserpine 利血平</li>
<li><strong>Propranolol（心得安） and other beta antagonist</strong></li>
</ul>
<p>useful in polytherapy in moderate to severe HTN</p>
<h3 id="2-Different-Side-Effects"><a href="#2-Different-Side-Effects" class="headerlink" title="2. Different Side Effects"></a>2. Different Side Effects</h3><p>CNS: sedation, depression, nightmares</p>
<p>ganglia: inhibition parasympathetic system as well</p>
<p>sympathetic end (NE release): ejection (-), postural hypotension</p>
<p><strong>block postsynaptic receptors: more selective effects</strong></p>
<h3 id="3-methyldopa"><a href="#3-methyldopa" class="headerlink" title="3. methyldopa"></a>3. methyldopa</h3><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210329235904526.png" srcset="/img/loading.gif" lazyload alt="image-20210329235904526" style="zoom:100%;" />

<ul>
<li>structure just like dopamine</li>
</ul>
<p>Enters CNS via Aromatic amino acid transport</p>
<p>Converts into alpha-methyldopamine &amp; alpha-methylNE </p>
<p>Partial alpha agonist: initial ↑BP by stimulating vascular receptor, &amp; <strong>then</strong> ↓ <strong>BP by stimulating CNS alpha-2 receptors</strong> </p>
<p>↓BP mainly by reducing PVR</p>
<h3 id="4-Clonidine"><a href="#4-Clonidine" class="headerlink" title="4. Clonidine"></a>4. Clonidine</h3><p>Specificity towards the presynaptic α2 receptors in the vasomotor center in the brainstem. This binding has a sympatholytic effect, suppresses release of norepinephrine, ATP, renin</p>
<p>↓<strong>BP by</strong> ↓<strong>cardiac output and</strong> ↓<strong>PVR</strong> <strong>(</strong> <strong>maintaining</strong> <strong>renal blood supply)</strong></p>
<h2 id="Major-sites-of-antihypertensive-drugs-1"><a href="#Major-sites-of-antihypertensive-drugs-1" class="headerlink" title="Major sites of antihypertensive drugs"></a>Major sites of antihypertensive drugs</h2><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330000834292.png" srcset="/img/loading.gif" lazyload alt="image-20210330000834292" style="zoom:100%;" />

<p>Ganglion‐blocking agents: historically, 1st generation of antihypertensive drugs (<strong>trimethaphan</strong>);</p>
<p>Competitively block Nicotinic Cholinoceptors on postganglionic Neurons in both sympathetic and parasympathetic ganglia., or they may directly block the nicotinic acetylcholine channel.</p>
<p>Most such drugs are no longer available clinically because of intolerable toxicities related to their primary action.</p>
<h3 id="1-Adrenergic-neuron-blocking-agents"><a href="#1-Adrenergic-neuron-blocking-agents" class="headerlink" title="1. Adrenergic neuron-blocking agents"></a>1. Adrenergic neuron-blocking agents</h3><p><strong>Guanethidine</strong></p>
<ul>
<li>replace NE, gradual depletion of NE store in the nerve ending</li>
</ul>
<p><strong>Reserpine</strong></p>
<ul>
<li>Block monoamine transporter VMAT, inhibits NE uptake into synaptic vesicles</li>
<li>uptake ≠ reuptake</li>
</ul>
<p>Antihypertensive effects</p>
<ul>
<li>short term: ↓CO, ↓ capacitance vessels;</li>
<li>long term: ↓ PVR sedation,</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330002558573.png" srcset="/img/loading.gif" lazyload alt="image-20210330002558573" style="zoom:100%;" />

<h4 id="Adrenoceptor-antagonists-1-the-prototype"><a href="#Adrenoceptor-antagonists-1-the-prototype" class="headerlink" title="Adrenoceptor antagonists (1): the prototype"></a>Adrenoceptor antagonists (1): the prototype</h4><p><strong>Propranolol</strong>: Nonselective beta-blocker, preventing reflex tachycardia, reduce mortality in heart failure</p>
<ul>
<li>Effects: ↓<strong>CO,</strong> CNS inhibition, ↓renin production</li>
</ul>
<p>Side effects: related to beta blockage at heart, bronchi, vessels, pancreas; <u>should not be discontinued abruptly</u></p>
<h4 id="Adrenoceptor-antagonists-2-good-for-asthma"><a href="#Adrenoceptor-antagonists-2-good-for-asthma" class="headerlink" title="Adrenoceptor antagonists (2): good for asthma"></a>Adrenoceptor antagonists (2): good for asthma</h4><p><strong>Metoprolol（美托洛尔）</strong>: relatively selective beta-1-blocker, 50-100-fold less potent than propranolol in blocking beta-2 receptor (expressed on metabolic organs)</p>
<p>Indications: HTN with asthma, diabetes, or peripheral vascular diseases</p>
<h4 id="Adrenoceptor-antagonists-6-Esmolol-艾司洛尔"><a href="#Adrenoceptor-antagonists-6-Esmolol-艾司洛尔" class="headerlink" title="Adrenoceptor antagonists (6): Esmolol 艾司洛尔"></a>Adrenoceptor antagonists (6): Esmolol 艾司洛尔</h4><p>Short T1&#x2F;2</p>
<ul>
<li>Property: beta-1-selective, and <strong>short T1&#x2F;2 (9-10 min)</strong></li>
<li>Indications: lowring BP in operation, postoperation, &amp; HTN emergencies</li>
</ul>
<p>Question: why is this short effective drug advantageous in dealing with HTN during operation ?</p>
<ul>
<li>A drug with short duration of action can be discontinued quickly, less danger for heart failure</li>
</ul>
<h4 id="Adrenoceptor-antagonists-7-alpha-1-specific-blockers"><a href="#Adrenoceptor-antagonists-7-alpha-1-specific-blockers" class="headerlink" title="Adrenoceptor antagonists (7): alpha-1-specific blockers"></a>Adrenoceptor antagonists (7): alpha-1-specific blockers</h4><p>Pra<strong>zosin</strong> (T1&#x2F;2: 4h)</p>
<ul>
<li>Mechanisms: <strong>block alpha-1; &amp; allow alpha-2 (-) feedback</strong></li>
<li>Prazosin 哌唑嗪</li>
<li>Decrease BP mainly via dilating vessels</li>
<li>More effective when combined with beta blockers or diuretics</li>
</ul>
<h4 id="Vasodilators-血管舒张剂"><a href="#Vasodilators-血管舒张剂" class="headerlink" title="Vasodilators 血管舒张剂"></a>Vasodilators 血管舒张剂</h4><p>Oral: outpatient</p>
<p>Parental: HTN emergencies</p>
<p>Calcium channel blockers: for both</p>
<p>Work best in combination with other drugs to <u>oppose the compensatory CV responses</u></p>
<p><strong>Oral vasodilators</strong>: Hydralazine vs minoxidil Mechanistic target still unknown</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330003226229.png" srcset="/img/loading.gif" lazyload alt="image-20210330003226229" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330003555511.png" srcset="/img/loading.gif" lazyload alt="image-20210330003555511" style="zoom:100%;" />

<ul>
<li><strong>Nitroprusside（硝普钠）</strong>: Dilates arterial &amp; venous vessels through <u>increased cGMP</u><ul>
<li>Increased CO in HTN with heart failure</li>
<li>Effects disappeared within 10 minutes, light sensitive</li>
</ul>
</li>
<li><strong>Diazoxide（氯甲苯噻嗪）</strong>: Dilates arterial vessels, <u>K+ channel opener (calcium channel close)</u><ul>
<li>Occasionally used to treat HTN emergencies</li>
<li>Side effects: extensive hypotension</li>
<li>Tips: Diazoxide and Thiozoxide are structurally similar, the former causes salt &amp; water retention, while the latter has been used as diuretics.</li>
<li>hypotention is very lethal, so there are not hypotension patients</li>
</ul>
</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330003708111.png" srcset="/img/loading.gif" lazyload alt="image-20210330003708111" style="zoom:100%;" />

<h4 id="CCBs-Calcium-channel-blockers-–-Mechanisms-of-Action"><a href="#CCBs-Calcium-channel-blockers-–-Mechanisms-of-Action" class="headerlink" title="CCBs (Calcium channel blockers) – Mechanisms of Action"></a>CCBs (Calcium channel blockers) – Mechanisms of Action</h4><p>Increase the time that Ca2+ channels are closed</p>
<p>Relaxation of the arterial smooth muscle but not much effect on venous smooth muscle</p>
<p>Significant reduction in afterload (blood coming out of heart), but not preload (blood goes into heart).</p>
<p>The α1C subunit of the L-type Ca2+ channel is the pore-forming subunit</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004101016.png" srcset="/img/loading.gif" lazyload alt="image-20210330004101016" style="zoom:100%;" />

<p>The expression and function of the α1C subunit is modulated by other smaller subunits</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004615345.png" srcset="/img/loading.gif" lazyload alt="image-20210330004615345" style="zoom:100%;" />

<p>The different binding sites of CCBs result in differing pharmacological effects</p>
<p>Use-dependent binding (targets cardiac cells)：</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004636968.png" srcset="/img/loading.gif" lazyload alt="image-20210330004636968" style="zoom:100%;" />

<p>Voltage-dependent binding (targets smooth muscle)：</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004655595.png" srcset="/img/loading.gif" lazyload alt="image-20210330004655595" style="zoom:100%;" />

<h4 id="Hemodynamic-Effects-of-CCBs"><a href="#Hemodynamic-Effects-of-CCBs" class="headerlink" title="Hemodynamic Effects of CCBs"></a>Hemodynamic Effects of CCBs</h4><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004824578.png" srcset="/img/loading.gif" lazyload alt="image-20210330004824578" style="zoom:100%;" />

<h4 id="CCBs-Pharmacokinetics"><a href="#CCBs-Pharmacokinetics" class="headerlink" title="CCBs: Pharmacokinetics"></a>CCBs: Pharmacokinetics</h4><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330004839694.png" srcset="/img/loading.gif" lazyload alt="image-20210330004839694" style="zoom:100%;" />

<p>Comparative Adverse Effects</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005010939.png" srcset="/img/loading.gif" lazyload alt="image-20210330005010939" style="zoom:100%;" />

<h2 id="Diuretic-agents"><a href="#Diuretic-agents" class="headerlink" title="Diuretic agents"></a>Diuretic agents</h2><p>Diuretics: for mild or moderate essential HTN,</p>
<ul>
<li>can lower10-15 mmHg;</li>
<li>natriuretic</li>
<li>direct vasodilatory effect decrease body volume</li>
</ul>
<p>Dietary sodium restriction is better for prevention</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005328041.png" srcset="/img/loading.gif" lazyload alt="image-20210330005328041" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005339494.png" srcset="/img/loading.gif" lazyload alt="image-20210330005339494" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005351503.png" srcset="/img/loading.gif" lazyload alt="image-20210330005351503" style="zoom:100%;" />

<ul>
<li>osmotic agents: inhibit water reabsorptions</li>
</ul>
<h3 id="1-basic-pharmacology-of-diuretic-agents-1"><a href="#1-basic-pharmacology-of-diuretic-agents-1" class="headerlink" title="1. basic pharmacology of diuretic agents (1)"></a>1. basic pharmacology of diuretic agents (1)</h3><p>Carbonic anhydrase inhibitor</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005555318.png" srcset="/img/loading.gif" lazyload alt="image-20210330005555318" style="zoom: 33%;" />

<p>Discovery history</p>
<ul>
<li><strong>sulfonamide（磺胺）</strong>: alkaline diuresis &amp; hyperchloremic</li>
</ul>
<p>metabolic acidosis</p>
<ul>
<li>Mechanism: ↑ NaHCO3 in urine</li>
</ul>
<p>Major clinical indications</p>
<ul>
<li>glaucoma（青光眼）: no systematic side effects</li>
<li>urinary alkalinization（尿碱化）: ↑excretion of weak acids</li>
<li>acute mountain sickness（极性高原病）</li>
</ul>
<p>Drugs available: <strong>Acetazolamide</strong>（乙酰脞胺）</p>
<h3 id="2-loop-diuretic-2"><a href="#2-loop-diuretic-2" class="headerlink" title="2. loop diuretic (2)"></a>2. loop diuretic (2)</h3><h4 id="Furosemide-（呋喃苯胺酸）"><a href="#Furosemide-（呋喃苯胺酸）" class="headerlink" title="Furosemide （呋喃苯胺酸）"></a>Furosemide （呋喃苯胺酸）</h4><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005652765.png" srcset="/img/loading.gif" lazyload alt="image-20210330005652765" style="zoom: 33%;" />

<p>Mechanism: ↓ NKCC2（sodium-(potassium)-chloride cotransporter 2 ）,</p>
<ul>
<li>then↓ NaCl reabsortion at think ascending limb</li>
</ul>
<p>Specified clinical indications (2)</p>
<ul>
<li>hyperkalemia (toxicity: hypokelemia) </li>
<li>acute renal failure</li>
<li>anion overdose</li>
</ul>
<h4 id="Thiazides-3"><a href="#Thiazides-3" class="headerlink" title="Thiazides (3)"></a>Thiazides (3)</h4><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005928677.png" srcset="/img/loading.gif" lazyload alt="image-20210330005928677" style="zoom:100%;" />

<p>Identified during synthesize more carbonic anhydrase inhibitors</p>
<p>Chemistry</p>
<ul>
<li>Share an unsubstituted sulfonamide group</li>
</ul>
<p>Mechanism: ↓ NaCl reabsorption by ↓Na+&#x2F;Cl‐ transporter</p>
<p>Major clinical indications: a frequently used subgroup</p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330005947362.png" srcset="/img/loading.gif" lazyload alt="image-20210330005947362" style="zoom: 33%;" />

<p>Drugs available:</p>
<ul>
<li>table 15-5: thiazide &amp; sulfonamide</li>
</ul>
<h4 id="Potassium-sparing-diuretics-4"><a href="#Potassium-sparing-diuretics-4" class="headerlink" title="Potassium-sparing diuretics (4)"></a>Potassium-sparing diuretics (4)</h4><p>Chemistry</p>
<ul>
<li>Spironolactone, aldosterone antagonist; </li>
<li>Eplerennone is a spironolactone analog but with higher selectivity</li>
<li>Amiloride &amp; triameterene: inhibitor of Na+ influx</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010211714.png" srcset="/img/loading.gif" lazyload alt="image-20210330010211714" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010217026.png" srcset="/img/loading.gif" lazyload alt="image-20210330010217026" style="zoom:33%;" />

<p>Applications:</p>
<ol>
<li>Primary or secondary hyperaldosteronism;</li>
<li>Combined used with other diuretics</li>
</ol>
<h4 id="Agents-altering-water-excretion-5a"><a href="#Agents-altering-water-excretion-5a" class="headerlink" title="Agents altering water excretion (5a)"></a>Agents altering water excretion (5a)</h4><p>Osmotic diuretics: <strong>mannitol（甘露醇）</strong></p>
<ul>
<li>Be filtered by the glomerulus, but not reabsorbed</li>
</ul>
<p>Applications:</p>
<ol>
<li>↑urine volume</li>
<li>↓intracranial &amp; intraocular pressure</li>
</ol>
<p>Antidiuretic hormone agonists</p>
<ul>
<li>Vasopressin and desmopressin: for central <strong>diabetes</strong>, <strong>insipidus</strong>（尿崩症）</li>
</ul>
<p>Antidiuretic hormone antagonists</p>
<ul>
<li>Conivaptan, lithium, demeclocycline<ul>
<li>For primary or secondary ADH（抗利尿激素） elevation</li>
</ul>
</li>
</ul>
<h3 id="3-Clinical-pharmacology-of-Diuretic-agents"><a href="#3-Clinical-pharmacology-of-Diuretic-agents" class="headerlink" title="3. Clinical pharmacology of Diuretic agents"></a>3. Clinical pharmacology of Diuretic agents</h3><p>Common reason:↓peripheral or pulmonary edema</p>
<ul>
<li>Hear failure: for pts CO maintained with high filling pressure</li>
<li>Kidney disease: loop diuretics are often the best (furosemide)</li>
<li>Hepatic cirrhosis: hypoalbuminemia, high aldosterone<ul>
<li>loop diuretics + aldosterone antagonist</li>
</ul>
</li>
</ul>
<h2 id="Major-sites-of-antihypertensive-drugs-2"><a href="#Major-sites-of-antihypertensive-drugs-2" class="headerlink" title="Major sites of antihypertensive drugs"></a>Major sites of antihypertensive drugs</h2><p><em>Compensatory response to vasodilators</em></p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010550604.png" srcset="/img/loading.gif" lazyload alt="image-20210330010550604" style="zoom:100%;" />

<p>Due to compensation, combination therapy with beta-Blocker and diutretics are desired</p>
<ul>
<li>Combination treatment means another class of blood pressure medication is added to the first drug to increase effectiveness.</li>
<li>Combination treatment for hypertension is individualized. It gives the best possible control of blood pressure with the fewest side effects.</li>
<li>When used in a drug combination, the diuretic has fewer side effects. It also boosts the blood-pressure-lowering effect of the other medication.</li>
<li>Sometimes, a beta-blocker is combined with an alpha-blocker. This may be useful for men who have hypertension and an enlarged prostate. The alpha-blocker may help both problems at the same time.</li>
</ul>
<h3 id="1-Site-of-action-for-Inhibitors-of-angiotensin"><a href="#1-Site-of-action-for-Inhibitors-of-angiotensin" class="headerlink" title="1. Site of action for Inhibitors of angiotensin"></a>1. Site of action for Inhibitors of angiotensin</h3><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330010849422.png" srcset="/img/loading.gif" lazyload alt="image-20210330010849422" style="zoom: 80%;" />

<h3 id="2-Inhibitors-of-angiotensin"><a href="#2-Inhibitors-of-angiotensin" class="headerlink" title="2. Inhibitors of angiotensin"></a>2. Inhibitors of angiotensin</h3><p>Two major types: </p>
<p>ACEI: Captopril, …..<strong>pril</strong></p>
<ul>
<li>↓Angiotensin II, aldosterone</li>
<li>More effective in Angiotensin I augumented heart damage</li>
</ul>
<p>Ang II receptor blockers: Losartan, …..<strong>sartan</strong></p>
<ul>
<li>blocking AT1 receptor</li>
<li>the baroreceptor: to prevent the hypotension</li>
</ul>
<p>When to start medication</p>
<ul>
<li>Diagnosis of essential HTN: excluding secondary HTN</li>
<li>Initial step: non‐pharmacologic<ul>
<li>Sodium restriction</li>
<li>Weight reduction</li>
<li>Low saturated fat and total fat</li>
<li>Physical exercise</li>
</ul>
</li>
</ul>
<p>How to treat HTN</p>
<ul>
<li>1 drug first, most of the pts requires 2 or more drugs</li>
<li>Concomitant disease<ul>
<li>Chronic kidney disease: ACEI</li>
<li>Angina: beta blocker, CCB</li>
<li>Heart failure: diuretics, beta blocker, ACEI, AT1 blocker</li>
</ul>
</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210330011037971.png" srcset="/img/loading.gif" lazyload alt="image-20210330011037971" style="zoom:100%;" />


                
              </div>
            
            <hr/>
            <div>
              <div class="post-metas my-3">
  
    <div class="post-meta mr-3 d-flex align-items-center">
      <i class="iconfont icon-category"></i>
      

<span class="category-chains">
  
  
    
      <span class="category-chain">
        
  <a href="/categories/Academic-Notebook/" class="category-chain-item">Academic Notebook</a>
  
  
    <span>></span>
    
  <a href="/categories/Academic-Notebook/Molecular-Pharmacology/" class="category-chain-item">Molecular Pharmacology</a>
  
  

  

      </span>
    
  
</span>

    </div>
  
  
    <div class="post-meta">
      <i class="iconfont icon-tags"></i>
      
        <a href="/tags/Molecular-Pharmacology/" class="print-no-link">#Molecular Pharmacology</a>
      
    </div>
  
</div>


              
  

  <div class="license-box my-3">
    <div class="license-title">
      <div>L7 Antihypertensive drugs including Vasodilators and anti-diuretics</div>
      <div>https://zhenyumi.github.io/posts/a09a12e3/</div>
    </div>
    <div class="license-meta">
      
        <div class="license-meta-item">
          <div>作者</div>
          <div>向海</div>
        </div>
      
      
        <div class="license-meta-item license-meta-date">
          <div>发布于</div>
          <div>2021年4月16日</div>
        </div>
      
      
      
        <div class="license-meta-item">
          <div>许可协议</div>
          <div>
            
              
              
                <a class="print-no-link" target="_blank" href="https://creativecommons.org/licenses/by/4.0/">
                  <span class="hint--top hint--rounded" aria-label="BY - 署名">
                    <i class="iconfont icon-cc-by"></i>
                  </span>
                </a>
              
            
          </div>
        </div>
      
    </div>
    <div class="license-icon iconfont"></div>
  </div>



              
                <div class="post-prevnext my-3">
                  <article class="post-prev col-6">
                    
                    
                      <a href="/posts/71c1856d/" title="L8 Agents used in Heart Failure and Cardiac Arrhythmias">
                        <i class="iconfont icon-arrowleft"></i>
                        <span class="hidden-mobile">L8 Agents used in Heart Failure and Cardiac Arrhythmias</span>
                        <span class="visible-mobile">上一篇</span>
                      </a>
                    
                  </article>
                  <article class="post-next col-6">
                    
                    
                      <a href="/posts/29d2c04c/" title="L6 Autonomic pharmacology：Adrenergic and Anti-adrenergic Drugs">
                        <span class="hidden-mobile">L6 Autonomic pharmacology：Adrenergic and Anti-adrenergic Drugs</span>
                        <span class="visible-mobile">下一篇</span>
                        <i class="iconfont icon-arrowright"></i>
                      </a>
                    
                  </article>
                </div>
              
            </div>

            
          </article>
        </div>
      </div>
    </div>

    <div class="side-col d-none d-lg-block col-lg-2">
      
  <aside class="sidebar" style="margin-left: -1rem">
    <div id="toc">
  <p class="toc-header">
    <i class="iconfont icon-list"></i>
    <span>目录</span>
  </p>
  <div class="toc-body" id="toc-body"></div>
</div>



  </aside>


    </div>
  </div>
</div>





  



  



  



  



  


  
  









    

    
      <a id="scroll-top-button" aria-label="TOP" href="#" role="button">
        <i class="iconfont icon-arrowup" aria-hidden="true"></i>
      </a>
    

    
      <div class="modal fade" id="modalSearch" tabindex="-1" role="dialog" aria-labelledby="ModalLabel"
     aria-hidden="true">
  <div class="modal-dialog modal-dialog-scrollable modal-lg" role="document">
    <div class="modal-content">
      <div class="modal-header text-center">
        <h4 class="modal-title w-100 font-weight-bold">搜索</h4>
        <button type="button" id="local-search-close" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body mx-3">
        <div class="md-form mb-5">
          <input type="text" id="local-search-input" class="form-control validate">
          <label data-error="x" data-success="v" for="local-search-input">关键词</label>
        </div>
        <div class="list-group" id="local-search-result"></div>
      </div>
    </div>
  </div>
</div>

    

    
  </main>

  <footer>
    <div class="footer-inner">
  
    <div class="footer-content">
       <a href="https://hexo.io" target="_blank" rel="nofollow noopener"><span>Hexo</span></a> <i class="iconfont icon-love"></i> <a href="https://github.com/fluid-dev/hexo-theme-fluid" target="_blank" rel="nofollow noopener"><span>Fluid</span></a> 
    </div>
  
  
  
</div>

  </footer>

  <!-- Scripts -->
  
  <script  src="https://lib.baomitu.com/nprogress/0.2.0/nprogress.min.js" ></script>
  <link  rel="stylesheet" href="https://lib.baomitu.com/nprogress/0.2.0/nprogress.min.css" />

  <script>
    NProgress.configure({"showSpinner":false,"trickleSpeed":100})
    NProgress.start()
    window.addEventListener('load', function() {
      NProgress.done();
    })
  </script>


<script  src="https://lib.baomitu.com/jquery/3.6.4/jquery.min.js" ></script>
<script  src="https://lib.baomitu.com/twitter-bootstrap/4.6.1/js/bootstrap.min.js" ></script>
<script  src="/js/events.js" ></script>
<script  src="/js/plugins.js" ></script>





  
    <script  src="/js/img-lazyload.js" ></script>
  




  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/tocbot/4.20.1/tocbot.min.js', function() {
    var toc = jQuery('#toc');
    if (toc.length === 0 || !window.tocbot) { return; }
    var boardCtn = jQuery('#board-ctn');
    var boardTop = boardCtn.offset().top;

    window.tocbot.init(Object.assign({
      tocSelector     : '#toc-body',
      contentSelector : '.markdown-body',
      linkClass       : 'tocbot-link',
      activeLinkClass : 'tocbot-active-link',
      listClass       : 'tocbot-list',
      isCollapsedClass: 'tocbot-is-collapsed',
      collapsibleClass: 'tocbot-is-collapsible',
      scrollSmooth    : true,
      includeTitleTags: true,
      headingsOffset  : -boardTop,
    }, CONFIG.toc));
    if (toc.find('.toc-list-item').length > 0) {
      toc.css('visibility', 'visible');
    }

    Fluid.events.registerRefreshCallback(function() {
      if ('tocbot' in window) {
        tocbot.refresh();
        var toc = jQuery('#toc');
        if (toc.length === 0 || !tocbot) {
          return;
        }
        if (toc.find('.toc-list-item').length > 0) {
          toc.css('visibility', 'visible');
        }
      }
    });
  });
</script>


  <script src=https://lib.baomitu.com/clipboard.js/2.0.11/clipboard.min.js></script>

  <script>Fluid.plugins.codeWidget();</script>


  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/anchor-js/5.0.0/anchor.min.js', function() {
    window.anchors.options = {
      placement: CONFIG.anchorjs.placement,
      visible  : CONFIG.anchorjs.visible
    };
    if (CONFIG.anchorjs.icon) {
      window.anchors.options.icon = CONFIG.anchorjs.icon;
    }
    var el = (CONFIG.anchorjs.element || 'h1,h2,h3,h4,h5,h6').split(',');
    var res = [];
    for (var item of el) {
      res.push('.markdown-body > ' + item.trim());
    }
    if (CONFIG.anchorjs.placement === 'left') {
      window.anchors.options.class = 'anchorjs-link-left';
    }
    window.anchors.add(res.join(', '));

    Fluid.events.registerRefreshCallback(function() {
      if ('anchors' in window) {
        anchors.removeAll();
        var el = (CONFIG.anchorjs.element || 'h1,h2,h3,h4,h5,h6').split(',');
        var res = [];
        for (var item of el) {
          res.push('.markdown-body > ' + item.trim());
        }
        if (CONFIG.anchorjs.placement === 'left') {
          anchors.options.class = 'anchorjs-link-left';
        }
        anchors.add(res.join(', '));
      }
    });
  });
</script>


  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/fancybox/3.5.7/jquery.fancybox.min.js', function() {
    Fluid.plugins.fancyBox();
  });
</script>


  <script>Fluid.plugins.imageCaption();</script>

  
      <script>
        if (!window.MathJax) {
          window.MathJax = {
            tex    : {
              inlineMath: { '[+]': [['$', '$']] }
            },
            loader : {
              load: ['ui/lazy']
            },
            options: {
              renderActions: {
                insertedScript: [200, () => {
                  document.querySelectorAll('mjx-container').forEach(node => {
                    let target = node.parentNode;
                    if (target.nodeName.toLowerCase() === 'li') {
                      target.parentNode.classList.add('has-jax');
                    }
                  });
                }, '', false]
              }
            }
          };
        } else {
          MathJax.startup.document.state(0);
          MathJax.texReset();
          MathJax.typeset();
          MathJax.typesetPromise();
        }

        Fluid.events.registerRefreshCallback(function() {
          if ('MathJax' in window && MathJax.startup.document && typeof MathJax.startup.document.state === 'function') {
            MathJax.startup.document.state(0);
            MathJax.texReset();
            MathJax.typeset();
            MathJax.typesetPromise();
          }
        });
      </script>
    

  <script  src="https://lib.baomitu.com/mathjax/3.2.2/es5/tex-mml-chtml.js" ></script>

  <script  src="/js/local-search.js" ></script>





<!-- 主题的启动项，将它保持在最底部 -->
<!-- the boot of the theme, keep it at the bottom -->
<script  src="/js/boot.js" ></script>


  

  <noscript>
    <div class="noscript-warning">博客在允许 JavaScript 运行的环境下浏览效果更佳</div>
  </noscript>
</body>
</html>
